Clostridium difficile is a ubiquitous spore-forming bacterium which causes toxin-mediated
diarrhoea and colitis in people whose gut microflora has been depleted by antimicrobial …

Clostridium difficile is the aetiological agent in ca. 20% of cases of antimicrobial-associated
diarrhoea in hospitalised adults. Diseases caused by this organism range from mild …

Clostridium difficile infections (CDIs) are traditionally seen in elderly and hospitalized
patients who have used antibiotic therapy. In the community, CDIs requiring a visit to a …

Little is known about Clostridium difficile infection (CDI) in Asia generally, and specifically in
Thailand. Given the high prevalence of inappropriate antibiotic usage in this region, CDI is …

Studies on the prevalence and diversity of Clostridium difficile in Thailand have been limited
to those derived from a few tertiary hospitals in Central Thailand. In this study, 145 C. difficile …

Clostridium difficile, an anaerobic toxigenic bacterium, causes a severe infectious colitis that
leads to significant morbidity and mortality worldwide. Both enhanced bacterial toxins and …

Background Current knowledge of the epidemiology of Clostridium difficile infection in Asia,
and in particular the Greater Mekong Subregion, is very limited. Only a few studies from …

The incidence and severity of Clostridium difficile infection (CDI) have dramatically
increased in the Western world in recent years. In contrast, CDI is rarely reported in China …

Clostridium difficile infection is the leading cause of diarrhoea in the industrialised world.
First identified in 1935, our knowledge about the clonal population structure, toxins and PCR …

The bacterium originally named Bacillus difficilis was later renamed Clostridium difficile
because of the difficulty associated with its isolation in the laboratory. C. difficile causes …